Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation

被引:38
|
作者
Jeong, K. W.
Kim, H-Z
Kim, S.
Kim, Y. S.
Choe, J.
机构
[1] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea
[2] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea
关键词
HPV; E6; E6AP; proteasome; ubiquitination;
D O I
10.1038/sj.onc.1209837
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The PDZ proteins such as hDLG, hScrib and MAGIs function as the membrane-associated protein scaffolds and have been shown to interact with the high-risk human papillomavirus (HPV) E6s. In this report, we identify a Golgi-associated PDZ protein, cystic fibrosis transmembrane regulator-associated ligand (CAL) as a cellular target of HPV16 E6 by the proteomic approach. The carboxy-terminal PDZ-binding motif of HPV16 E6 specifically interacts with the PDZ domain of CAL, and the interaction enhances proteasome-mediated degradation of CAL. HPV16 E6 interacts with CAL more strongly and degrades it better than HPV18 E6 owing to the more compatible PDZ-binding motif. CAL is ubiquitinated by the E6/E6-associated protein (E6AP) complex or by E6AP alone, albeit less efficiently, which indicates that it could be a normal target of E6AP. Although it downregulates CAL at the transcript level, small interfering RNA-induced depletion of HPV16 E6 in Caski cells stabilizes CAL at the protein level, suggesting that HPV16 E6 mediates the proteasomal degradation of CAL in HPV-positive cervical cancer cells. HPV16 E6 may tightly regulate the vesicular trafficking processes by interacting with CAL, and such a modification can contribute to the development of cervical cancer.
引用
收藏
页码:487 / 499
页数:13
相关论文
共 32 条
  • [1] Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation
    K W Jeong
    H-Z Kim
    S Kim
    Y S Kim
    J Choe
    Oncogene, 2007, 26 : 487 - 499
  • [2] Determinants of Stability for the E6 Protein of Papillomavirus Type 16
    Liu, Yuqi
    Cherry, Jonathan J.
    Dineen, Joseph V.
    Androphy, Elliot J.
    Baleja, James D.
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 386 (04) : 1123 - 1137
  • [3] Hydrogen Peroxide Inhibits Hepatitis C Virus Replication by Downregulating Hepatitis C Virus Core Levels through E6-Associated Protein-Mediated Proteasomal Degradation
    Yoon, Hyunyoung
    Jang, Kyung Lib
    CELLS, 2024, 13 (01)
  • [4] Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex
    Gewin, L
    Myers, H
    Kiyono, T
    Galloway, DA
    GENES & DEVELOPMENT, 2004, 18 (18) : 2269 - 2282
  • [5] Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein
    Brimer, Nicole
    Lyons, Charles
    Pol, Scott B. Vande
    VIROLOGY, 2007, 358 (02) : 303 - 310
  • [6] Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6
    Camus, S.
    Menendez, S.
    Cheok, C. F.
    Stevenson, L. F.
    Lain, S.
    Lane, D. P.
    ONCOGENE, 2007, 26 (28) : 4059 - 4070
  • [7] Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6
    S Camus
    S Menéndez
    C F Cheok
    L F Stevenson
    S Laín
    D P Lane
    Oncogene, 2007, 26 : 4059 - 4070
  • [8] Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6
    Duffy, CL
    Phillips, SL
    Klingelhutz, AJ
    VIROLOGY, 2003, 314 (01) : 196 - 205
  • [9] CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend
    Kim, Kevin H.
    Greenfield, William W.
    Cannon, Martin J.
    Coleman, Hannah N.
    Spencer, Horace J.
    Nakagawa, Mayumi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (01) : 63 - 70
  • [10] The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation
    Shimada, Masaru
    Yamashita, Akio
    Saito, Manami
    Ichino, Motohide
    Kinjo, Takao
    Mizuki, Nobuhisa
    Klinman, Dennis M.
    Okuda, Kenji
    SCIENTIFIC REPORTS, 2020, 10 (01)